0.5MG RDY 525 (Tacrolimus 0.5 mg)
Pill with imprint 0.5MG RDY 525 is Yellow, Capsule-shape and has been identified as Tacrolimus 0.5 mg. It is supplied by Dr. Reddy’s Laboratories Inc..
Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal; crohn's disease; graft-versus-host disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 0.5MG RDY 525
- 0.5MG RDY 525
- 0.5 mg
- Prescription only
- Drug Class:
- Calcineurin inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Dr. Reddy’s Laboratories Inc.
- Inactive Ingredients:
- croscarmellose sodium
ferric oxide red
ferric oxide yellow
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
|NDC Code||Labeler / Repackager|
|68084-0449||Amerisource Health Services|
More about tacrolimus
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 32 Reviews – Add your own review/rating
- Drug class: calcineurin inhibitors
- Tacrolimus oral and injection
- Tacrolimus Capsules
- Tacrolimus Extended-Release Capsules
- Tacrolimus Extended-Release Tablets
- Tacrolimus Injection
- ... +2 more
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.